Assessment of the Severity of Chronic Obstructive Pulmonary Disease in Combination with Bronchial Asthma

To date, respiratory diseases represent not only a medical but also a socio-economic problem, which is the most widespread according to the World Health Organisation, ‘the number of people suffering from bronchial asthma (BA) is 300 million, and chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death’. In clinical practice, patients with characteristic symptoms of both nosological forms are often encountered, which leads to certain difficulties in diagnosis and treatment. Despite the similarity of symptoms, these diseases differ from the histological point of view, are characterised by different physiological disorders and differ in their clinical manifestations. Nowadays the main task of specialists is to slow down the progression of BA and COPD and their combination, taking into account the peculiarities of pathogenetic pathways of diseases, to improve the quality of life of patients and to prevent the development of complications.